CD19 and myeloid sarcoma: There were no statistically significant differences in the IL-10–producing B cell subsets between MS and HD, whereas more IL-10–positive B cells were observed in the CD19+CD24highCD38high subpopulation than in total B cells for both MS and HD (Figure 5A).